Methylation profiling

Dataset Information

0

DNA methylation signatures correlate with response to immune checkpoint inhibitors in metastatic melanoma


ABSTRACT: DNA methylation profiles were recently proposed to have predictive value in various solid tumors. Therefore, we analyzed DNA methylation profiles of patients with stage IV metastatic melanoma, receiving first-line immune checkpoint inhibitors (ICIs) and correlated those with radiological response (iRECIST). Overall, 81 tissue samples from 71 patients with metastatic melanoma (27 (38.0%) female, 44 (62.0%) male) were investigated; median progression free survival was 8.5 months (0 – 104.1 months) and median overall survival was 30.6 months (0 – 104.1 months), respectively. 29 (40.8%) patients achieved an objective response. DNA methylation analyses revealed signatures correlating with radiological response to ICIs. Based on the 500 mostly differentially methylated genes, three clusters were identified with the majority of responders being in cluster 1 (12/12) and cluster 2 (12/24), and non-responders in cluster 3 (39/45). Our findings indicate that tumor DNA methylation profiling may be used as a predictor for ICI-response in patients with metastatic melanoma.

ORGANISM(S): Homo sapiens

PROVIDER: GSE235122 | GEO | 2024/04/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-07-13 | PXD017201 | Pride
2024-06-20 | GSE262550 | GEO
2012-12-01 | E-MEXP-3730 | biostudies-arrayexpress
2023-02-02 | PXD035347 | Pride
2022-01-13 | GSE186143 | GEO
2022-01-13 | GSE189126 | GEO
2022-01-13 | GSE189125 | GEO
2021-02-04 | GSE165170 | GEO
2012-05-01 | E-GEOD-30812 | biostudies-arrayexpress
2022-04-10 | E-MTAB-11605 | biostudies-arrayexpress